Comparison of phenothiazine and nonphenothiazine neuroleptics according to psychopathology, side effects and computerized EEG.
D000513:Alpha Rhythm; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003201:Computers; D004569:Electroencephalography; D005260:Female; D005476:Fluphenazine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006220:Haloperidol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010300:Parkinson Disease / Q000188:drug therapy; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D010919:Placebos; D011352:Procyclidine / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D012890:Sleep; D013888:Thiothixene / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D010919:Placebos; D013888:Thiothixene; D011352:Procyclidine; D006220:Haloperidol; D005476:Fluphenazine